These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2663834)
21. Behavioral effects of haloperidol in young autistic children. An objective analysis using a within-subjects reversal design. Cohen IL; Campbell M; Posner D; Small AM; Triebel D; Anderson LT J Am Acad Child Psychiatry; 1980; 19(4):665-77. PubMed ID: 7204797 [No Abstract] [Full Text] [Related]
22. A comparison of haloperidol and behavior therapy and their interaction in autistic children. Campbell M; Anderson LT; Meier M; Cohen IL; Small AM; Samit C; Sachar EJ J Am Acad Child Psychiatry; 1978; 17(4):640-55. PubMed ID: 370186 [No Abstract] [Full Text] [Related]
23. A comparison of haloperidol, behavior therapy, and their interaction in autistic children [proceedings]. Campbell M; Anderson LT; Meier M Psychopharmacol Bull; 1979 Apr; 15(2):84-6. PubMed ID: 373009 [No Abstract] [Full Text] [Related]
24. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Campbell M; Small AM; Green WH; Jennings SJ; Perry R; Bennett WG; Anderson L Arch Gen Psychiatry; 1984 Jul; 41(7):650-6. PubMed ID: 6428371 [TBL] [Abstract][Full Text] [Related]
25. A comparison of live and videotape ratings: clomipramine and haloperidol in autism. Sanchez LE; Adams PB; Uysal S; Hallin A; Campbell M; Small AM Psychopharmacol Bull; 1995; 31(2):371-8. PubMed ID: 7491394 [TBL] [Abstract][Full Text] [Related]
26. [Psychopharmacology of autism]. Chabrol H; Bonnet D; Roge B Encephale; 1996; 22(3):197-203. PubMed ID: 8767048 [TBL] [Abstract][Full Text] [Related]
27. A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using crossover design. Naruse H; Nagahata M; Nakane Y; Shirahashi K; Takesada M; Yamazaki K Acta Paedopsychiatr; 1982 Aug; 48(4):173-84. PubMed ID: 6756027 [No Abstract] [Full Text] [Related]
28. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Sallee FR; Nesbitt L; Jackson C; Sine L; Sethuraman G Am J Psychiatry; 1997 Aug; 154(8):1057-62. PubMed ID: 9247389 [TBL] [Abstract][Full Text] [Related]
29. Effects of small doses of haloperidol on autistic children. Hoshino Y; Yashima Y; Ishige K; Kaneko M; Kumashiro H Fukushima J Med Sci; 1979; 26(1-2):43-54. PubMed ID: 521004 [No Abstract] [Full Text] [Related]
30. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. Campbell M; Armenteros JL; Malone RP; Adams PB; Eisenberg ZW; Overall JE J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):835-43. PubMed ID: 9183140 [TBL] [Abstract][Full Text] [Related]
31. The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study. Rimland B; Callaway E; Dreyfus P Am J Psychiatry; 1978 Apr; 135(4):472-5. PubMed ID: 345827 [TBL] [Abstract][Full Text] [Related]
32. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Arvanitis LA; Miller BG Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900 [TBL] [Abstract][Full Text] [Related]
33. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study. Fuglum E; Schillinger A; Andersen JB; Belstad BE; Jensen D; Müller F; Müller KJ; Schulstad B; Elgen K Pharmatherapeutica; 1989; 5(5):285-91. PubMed ID: 2568639 [TBL] [Abstract][Full Text] [Related]
34. A controlled crossover study of triiodothyronine in autistic children. Campbell M; Small AM; Hollander CS; Korein J; Cohen IL; Kalmijn M; Ferris S J Autism Child Schizophr; 1978 Dec; 8(4):371-81. PubMed ID: 365855 [TBL] [Abstract][Full Text] [Related]
35. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children. Meiselas KD; Spencer EK; Oberfield R; Peselow ED; Angrist B; Campbell M J Clin Psychopharmacol; 1989 Jun; 9(3):207-9. PubMed ID: 2500463 [TBL] [Abstract][Full Text] [Related]
36. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871 [TBL] [Abstract][Full Text] [Related]
37. A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease. Devanand DP; Sackeim HA; Brown RP; Mayeux R Arch Neurol; 1989 Aug; 46(8):854-7. PubMed ID: 2667504 [TBL] [Abstract][Full Text] [Related]
38. Effects of pyridoxine and magnesium on autistic symptoms--initial observations. Lelord G; Muh JP; Barthelemy C; Martineau J; Garreau B; Callaway E J Autism Dev Disord; 1981 Jun; 11(2):219-30. PubMed ID: 6765503 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115 [TBL] [Abstract][Full Text] [Related]
40. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]